<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Peng J</submitter><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of General Medical Sciences</funding><funding>University of Kentucky (UK)</funding><funding>University of Kentucky</funding><funding>U.S. Department of Defense</funding><funding>U.S. Department of Defense (United States Department of Defense)</funding><funding>NCI NIH HHS</funding><funding>U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)</funding><funding>U.S. Department of Health &amp;amp; Human Services | National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><pagination>4190-4204</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12503065</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>44(43)</volume><pubmed_abstract>Although the involvement of polo-like kinase 1 (PLK1) in metabolic reprogramming from oxidative phosphorylation (OXPHOS) to glycolysis has been previously described, the underlying molecular mechanism remains unclear. Pyruvate dehydrogenase (PDH) catalyzes the conversion of pyruvate into acetyl-CoA, the starting material for the tricarboxylic acid (TCA) cycle. In a companion study by Zhang et al., we demonstrated that PLK1 phosphorylation of PDHA1 at threonine 57 (PDHA1-T57) drives its protein degradation via mitophagy activation. Using a stable-isotope resolved metabolomics (SIRM) approach, we now show that PLK1 phosphorylation of PDHA1-T57 results in metabolic reprogramming from OXPHOS to glycolysis. Notably, cells mimicking PDHA1-T57 phosphorylation rely more on the aspartate-malate shu</pubmed_abstract><journal>Oncogene</journal><pubmed_title>PLK1-mediated PDHA1 phosphorylation drives metabolic reprogramming in lung cancer.</pubmed_title><pmcid>PMC12503065</pmcid><funding_grant_id>P30CA177558</funding_grant_id><funding_grant_id>R01 CA264652</funding_grant_id><funding_grant_id>CA157429</funding_grant_id><funding_grant_id>P30 GM127211</funding_grant_id><funding_grant_id>CA264652</funding_grant_id><funding_grant_id>CA256893</funding_grant_id><funding_grant_id>DoD-HT9425-24-1-0442</funding_grant_id><funding_grant_id>P30 CA177558</funding_grant_id><funding_grant_id>R01 CA272483</funding_grant_id><funding_grant_id>CA272483</funding_grant_id><funding_grant_id>R01 CA256893</funding_grant_id><funding_grant_id>R01 CA196634</funding_grant_id><funding_grant_id>R01 CA157429</funding_grant_id><funding_grant_id>CA196634</funding_grant_id><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Wang R</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Rao X</pubmed_authors><pubmed_authors>Allison DB</pubmed_authors><pubmed_authors>Katz W</pubmed_authors><pubmed_authors>Kong Y</pubmed_authors><pubmed_authors>Peng J</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>PLK1-mediated PDHA1 phosphorylation drives metabolic reprogramming in lung cancer.</name><description>Although the involvement of polo-like kinase 1 (PLK1) in metabolic reprogramming from oxidative phosphorylation (OXPHOS) to glycolysis has been previously described, the underlying molecular mechanism remains unclear. Pyruvate dehydrogenase (PDH) catalyzes the conversion of pyruvate into acetyl-CoA, the starting material for the tricarboxylic acid (TCA) cycle. In a companion study by Zhang et al., we demonstrated that PLK1 phosphorylation of PDHA1 at threonine 57 (PDHA1-T57) drives its protein degradation via mitophagy activation. Using a stable-isotope resolved metabolomics (SIRM) approach, we now show that PLK1 phosphorylation of PDHA1-T57 results in metabolic reprogramming from OXPHOS to glycolysis. Notably, cells mimicking PDHA1-T57 phosphorylation rely more on the aspartate-malate shu</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-04T14:49:33.093Z</modification><creation>2026-05-10T03:11:35.695Z</creation></dates><accession>S-EPMC12503065</accession><cross_references><pubmed>40957950</pubmed><doi>10.1038/s41388-025-03571-1</doi></cross_references></HashMap>